Академический Документы
Профессиональный Документы
Культура Документы
Company presentation
May 2011
www.nanostart.de
1/21
Nanostart AG
2011 .
/ Translation / bersetzung: www.rusdoc.com
www.nanostart.de
2/21
Company profile
With a unique track record of 9 exits (5 IPOs and 4 trade/asset sales), Nanostart is
the leading nanotech venture capital company and one of the most successful
investors in nanotechnology.
Number of investments: 20
Subsidiary: Singapore
www.nanostart.de
Current portfolio:
3/21
(9 : 5
IPO 4 / ),
Nanostart ,
.
, ,
: 2003
: 20
: 2005
: 9
: ()
: ()
(IPO):
- , Nasdaq (
) (2),
- (3)
/ : (3),
(1)
:
(2), (3), (4)
www.nanostart.de
: 21 .
: 90 .
4/21
Growth financing to
nanotechnology start-up
companies
International portfolio,
hot spots in cleantech,
life sciences, ITelectronics, materials
www.nanostart.de
Locations:
Frankfurt, Berlin and
Singapore, Russia (soon
to come)
Global network
5/21
Nanostart:
, " ",
, IT-,
www.nanostart.de
, ,
50
:
,
6/21
Management and
commercialization
expertise
consulting
Business model
investment: either
direct or through a
fund
Portfolio
companies
Exit
contacts
Invested capital
per deal
EUR1-10 mn
Network
www.nanostart.de
7/21
(IPO)
1-10 .
www.nanostart.de
8/21
www.nanostart.de
9/21
Nanostart AG
(Marco Beckmann) ()
Nanostart n
n
Hauck & Aufhuser Nanotech n
2001 .
(Stefan Elsser) ().
3i ( ),
n 10-
Technologieholding 3i n .
(Hansjrg Ruof) ()
3i n
12 n - .
www.nanostart.de
10/21
www.nanostart.de
11/21
Nanostart Asia
(Andreas Krll) ,
().
Ebner & Stolz Deloitte & Touche n
(Deutsche Bank) n
.
(Lerwen Liu) ()
nABACUS Partners ()
n / -
n , .
(Sidra Sehar Ahmed) ().
n
,
( ).
(Celine Tan) ().
Strategic Investment Group SK Energy International, (
)
n
(
).
www.nanostart.de
12/21
www.nanostart.de
13/21
Nanostart
www.nanostart.de
14/21
Trade sale
to
Teijin Ltd
2010
Asset sale
to
Zicom Group
Asset sale
to Roche and
IRIS International
2010
Share
placement
Share
placement
2007
2006
Share
placement
Share
placement
2005
2005
www.nanostart.de
IPO/partial exit
2010
2007-2010
Trade sale
to
Heamonetics
2006
IPO
2006
15/21
Teijin Ltd
2010
Roche and IRIS
International
Zicom Group
2010
2010
2007-2010
Trade sale
to
Heamonetics
2006
IPO
2007
2006
2005
2005
www.nanostart.de
IPO/
2006
Nanostart
16/21
www.nanostart.de
17/21
Nanostart:
www.nanostart.de
18/21
www.nanostart.de
19/21
Nanostart
www.nanostart.de
20/21
Portfolio example:
MagForce Nanotechnologies AG
www.nanostart.de
21/21
:
MagForce Nanotechnologies
www.nanostart.de
22/21
using nanoparticles
NanoTherm therapy is a novel therapy for the treatment of solid tumors
MagForce is preparing for European product launch of NanoTherm therapy, which is expected in early
2011
Technology
Nanoparticles containing ironoxide are injected into solid tumors in a procedure similar to a biopsy. Due to
the special coating the nanoparticles aggregate and stay in place.
The patient is then placed in a magnetic field applicator. The nanoparticles begin to oscillate and warmth is
produced from directly within the tumor tissue. Depending on the temperature reached and length of
treatment, the tumor cells are either directly destroyed or sensitized for the accompanying chemotherapy or
radiation.
Investment history
In EUR million
Invested amount
EUR 5.06 mn
Share in MagForce
66 %
Proceeds
EUR 17.6 mn
Remaining stake
EUR 70 mn
www.nanostart.de
23/21
: MagForce Nanotechnologies
,
.
NanoTherm - () .
2011 MagForce (
NanoTherm) .
, , ,
. .
. ,
.
, ,
.
5,06 .
MagForce
66 %
17,6 .
70 .
www.nanostart.de
24/21
in 2011
Nanostart provides its portfolio holdings not only with growth capital, but also with
commerzialisation expertise and network contacts
www.nanostart.de
25/21
MagForce:
Nanostart
in 2011
Nanostart
,
www.nanostart.de
26/21
Nanostart Asia
www.nanostart.de
27/21
Nanostart Asia
www.nanostart.de
28/21
2009
2010
2011
www.nanostart.de
29/21
2009
: BioMers,
,
.
2010
: Microlight Sensors
2011
Nanostart
.
, 1- 2011 .
www.nanostart.de
30/21
Perm
Moskau
Alongside with the Singapore Early Stage Venture Fund I, Kama Fund First is
already Nanostarts second regional nanotech fund
www.nanostart.de
31/21
:
Nanostart
50 ( )
:
Nanostart
Nanostart 3%
25%
Nanostart
Nanostart. - Singapore
Early Stage Venture Fund I
Nanostart
www.nanostart.de
32/21
Why Russia?
Favorable investment climate
As one of the BRIC nations, Russia is one of the four most promising and fastest growing economies
in the world
Multibillion investment programs enforce modernization process
Huge domestic market and growing middle class lead to high consumer demand and enhance growth
www.nanostart.de
33/21
- ,
, ., , , ,
,
:
:
www.nanostart.de
34/21
Novosibirsk
The 3rd largest educational system in the nation: More than 40 universities and colleges,
20 research centers and laboratories, 11 innovation centers and 9 centers of innovative
competence generate skilled personnel for the Asian part of Russia
Located in the center of Russia and at the intersection of several trading lines,
Novosibirsk has a favorable geographical position
www.nanostart.de
35/21
,
,
3- : 40
, 20 - , 11
9
www.nanostart.de
36/21
Stock information*
Trading platforms:
Stock price:
Market cap:
Shares outstanding:
Analysts rating
Date
Analyst/Company
09-May-11
Buy
32.00
21-Jan-11
Buy
35.00
01-Aug-10
Buy
47.50
22-Apr-10
Buy
50.94
www.nanostart.de
Recommendation
Price target
37/21
:
:
:
: XETRA (NNS.DE)
: OTCQX (NASRY)
16,00
95
5,94
* 10 2011 .
09 2011
32,00
21 2011
(Malte Schaumann) /
Warburg Research
35,00
01 2010
47,50
22 2010
50,94
www.nanostart.de
38/21
Contact
Marco Beckmann
Chief Executive Officer
phone +49 - (0)69 - 2193 96 00
fax
+49 - (0)69 - 2193 96 150
marco.beckmann@nanostart.de
fax
Stefan.elsser@nanostart.de
www.nanostart.de
39/21
(Marco Beckmann)
.: +49 - (0)69 - 2193 96 00
: +49 - (0)69 - 2193 96 150
marco.beckmann@nanostart.de
(Stefan Elsser)
.: +49 - (0)69 - 2193 96 00
www.nanostart.de
40/21
Disclaimer
The information provided in this presentation does not constitute either an investment
recommendation or an offer or invitation for the purchase or sale of investment
instruments or for the execution of trading transactions or any other legally binding
contracts. The information and opinions provided herein have been provided by
Nanostart AG exclusively for private use and for general informational purposes, and
they are subject to change at any time without prior notice. Nanostart AG assumes no
liability whatsoever (either direct or implicit) for the correctness, completeness or
timeliness of any of the information and opinions provided herein.
Nanostart AG specifically disclaims any responsibility to remove information from this
presentation which is no longer current, or to specifically mark it as such. The
information in this presentation should not be used as the basis for investment, legal,
tax or other such decisions for which professional advice should be obtained, and
investment or other decisions should not be undertaken solely on the basis of the
information provided herein. We recommend that you speak to a qualified advisor
before undertaking any such decisions.
Pictures: Fotolia.de; Nanostart AG; MagForce Nanotechnologies AG, Namos GmbH, Curiox, Lumiphore, BioMers, BioMicro,
NanoGram, Holmenkol AG, ItN Nanovation AG
www.nanostart.de
41/21
, ,
,
.
Nanostart AG
, .
. Nanostart AG
( ) ,
, .
Nanostart AG
, .
, ,
, , ,
. ,
.
.
: Fotolia.de; Nanostart AG; MagForce Nanotechnologies AG, Namos GmbH, Curiox, Lumiphore, BioMers, BioMicro, NanoGram,
Holmenkol AG, ItN Nanovation AG
www.nanostart.de
42/21